Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Abbott Says Decision To Discontinue Cylert Stems From Demand, Not Safety

Mar 24 2005

• By Sue Sutter

Related Content

Crestor, Serevent Are Among Problem Drugs Cited By FDA Safety Reviewer

Nov 18 2004

Crestor May Be Safer Than Other Statins, FDA Tells Public Citizen

Mar 14 2005

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window